News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
166 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (22311)
Month
January (2433)
February (2868)
March (3029)
April (3116)
May (3356)
June (2727)
July (2287)
August (2495)
Day
1 (121)
2 (96)
3 (8)
5 (6)
6 (79)
7 (151)
8 (89)
9 (80)
10 (30)
13 (139)
14 (106)
15 (102)
16 (136)
17 (48)
19 (25)
20 (83)
21 (88)
22 (115)
23 (109)
24 (78)
26 (5)
27 (123)
28 (100)
29 (166)
30 (163)
31 (41)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
Day
1
2
3
5
6
7
8
9
10
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
31
Earnings
Biotechs bring big launches and pharma rivalries into Q2 earnings period
With the second quarter earnings period underway,
BioSpace
examines five biotechs with meaningful catalysts that analysts and investors are watching.
July 29, 2026
·
6 min read
·
Annalee Armstrong
Press Releases
Curebound Strengthens Leadership with Three Key Executive Hires
July 29, 2026
·
5 min read
FDA
Capricor and Replimune prep for FDA adcomms, Q2 earnings roll on, Sarepta’s new leader, more
The FDA published briefing documents ahead of advisory committee meetings for therapies from Capricor Therapeutics and Replimune indicate an uphill battle for the biotechs; GSK and AstraZeneca outline ambitious plans in second quarter presentations; Sarepta taps Michael Severino as its new CEO; and Amgen launches its official defense of Tavneos.
July 29, 2026
·
1 min read
·
Heather McKenzie
Press Releases
Ultragenyx to Host Conference Call for Second Quarter 2026 Financial Results and Corporate Update
July 29, 2026
·
1 min read
Press Releases
Kymera Therapeutics to Report Second Quarter 2026 Financial Results on August 5, 2026
July 29, 2026
·
1 min read
Press Releases
Ocugen to Host Conference Call on Thursday, August 6 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2026 Financial Results
July 29, 2026
·
2 min read
Press Releases
MannKind to Report Second Quarter Financial Results and Host Conference Call on August 5, 2026
July 29, 2026
·
1 min read
Press Releases
Martin Madaus Elected to Haemonetics Board of Directors
July 29, 2026
·
2 min read
Press Releases
QT Imaging Holdings Announces Results of 2026 Annual Stockholder Meeting
July 29, 2026
·
1 min read
Press Releases
Agilent to Announce Third-Quarter Fiscal Year 2026 Financial Results on Aug. 26
July 29, 2026
·
1 min read
1 of 17
Next
